Pre-Open Stock Movers 11/08: (AUTL) (TTD) (BLNK) Higher; (EHTH) (BLUE) (TSLA) Lower (more...)
Pre-Open Stock Movers:
Autolus Therapeutics plc (Nasdaq: AUTL) 27.2% HIGHER; announced that the two companies have entered into a strategic collaboration and financing agreement under which funds managed by Blackstone (NYSE: BX) will provide up to $250 million in equity and product financing to support Autolus advancement of its CD19 CAR T cell investigational therapy product candidate, obecabtagene autoleucel (obe-cel), as well as next generation product therapies of obe-cel in B-cell malignancies.
eHealth (NASDAQ: EHTH) 22.5% LOWER; reported Q3 EPS of ($1.78), $0.76 worse than the analyst estimate of ($1.02). Revenue for the quarter came in at $63.9 million versus the consensus estimate of $93.04 million. eHealth sees FY2021 EPS of ($0.45)-($1.13), versus the consensus of $2.91. eHealth sees FY2021 revenue of $535-575 million, versus the consensus of $690.74 million.
The Trade Desk Inc. (NASDAQ: TTD) 22% HIGHER; reported Q3 EPS of $0.18, $0.03 better than the analyst estimate of $0.15. Revenue for the quarter came in at $301.1 million versus the consensus estimate of $283.52 million. The Trade Desk Inc. sees Q4 2021 revenue of at least $388 million, versus the consensus of $387 million.
Blink Charging (NASDAQ: BLNK) +15.5% HIGHER; gains on infrastructure bill passage
EVgo Inc. (NASDAQ: EVGO) 14.6% HIGHER; announced that it was awarded several grants from the Pennsylvania Department of Environmental Protection (DEP) to install new high powered 350 kW DC fast charging stations. These projects are supported by the latest funding from the Pennsylvania DEPs Driving PA Forward initiative and add to the 3 stations and 10 DCFC chargers EVgo has already energized.
ChargePoint Holdings, Inc. (NASDAQ: CHPT) 14.2% HIGHER; gains on infrastructure bill passage
Coty (NYSE: COTY) 11% HIGHER; reported Q1 EPS of $0.08, $0.05 better than the analyst estimate of $0.03. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.36 billion. Coty sees FY2022 EPS of $0.19-$0.23, versus the consensus of $0.20. Also, announced a definitive agreement to sell an approximate 4.7% stake in Wella to KKR in exchange for the redemption of approximately 56% of KKRs remaining convertible preferred shares in Coty.
Marathon Digital Holdings, Inc. (NASDAQ: MARA) 8.6% HIGHER; gains as bitcoin, other cryptos rally
Microstrategy, Inc. (NASDAQ: MSTR) 7% HIGHER; gains as bitcoin, other cryptos rally
Riot Blockchain (NASDAQ: RIOT) 7% HIGHER; gains as bitcoin, other cryptos rally
Caterpillar (NYSE: CAT) 5.2% HIGHER; Infrastructure bill passage. Also, Baird added the stock as a Fresh Pick.
U.S. Steel (NYSE: X) 5% HIGHER; gains on the passage of the infrastructure bill.
bluebird bio, Inc. (NASDAQ: BLUE) 5% LOWER; downgraded to Sell at Goldman and Morgan Stanley.
Tesla (NASDAQ: TSLA) 4.2% LOWER; falls after millions of Twitter users instructed CEO Elon Musk to sell a tenth of his stake in the electric carmaker. On Saturday, Musk tweeted a poll to ask nearly 63 million of his followers whether he should sell 10% of his holdings. More than 3.5 million votes were cast with 57.9% voting “yes.”
Coinbase Global, Inc. (NASDAQ: COIN) 3.3% HIGHER; gains as bitcoin, other cryptos rally
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) 2.2% HIGHER; announced additional positive results from a Phase 3 trial jointly run with the National Institute of Allergy and Infectious Diseases (NIAID), which assessed use of a single dose of investigational REGEN-COV® (1,200 mg administered via 4 subcutaneous injections) to prevent COVID-19 in uninfected individuals. The new analyses show REGEN-COV reduced the risk of contracting COVID-19 (i.e., laboratory-confirmed symptomatic SARS-CoV-2 infections) by 81.6% during the pre-specified follow-up period (months 2-8), maintaining the 81.4% risk reduction during the first month after administration, which was previously reported in The New England Journal of Medicine.
TreeHouse Foods, Inc. (NYSE: THS) 1.5% HIGHER; announced that its Board of Directors has approved a plan to explore strategic alternatives, including a possible sale of the Company or a transaction to allow the Company to focus on its higher growth Snacking and Beverages business by divesting a significant portion of its Meal Prep business. The determination follows the Company's ongoing, Board-led strategic review which began earlier this year. TreeHouse has retained Evercore as its financial advisor and Sidley Austin LLP and Gibson Dunn as its legal counsel to assist with the exploration of alternatives.